CN101829193A - Medicine composite for treating cervical erosion and preparation method thereof - Google Patents
Medicine composite for treating cervical erosion and preparation method thereof Download PDFInfo
- Publication number
- CN101829193A CN101829193A CN201010182462A CN201010182462A CN101829193A CN 101829193 A CN101829193 A CN 101829193A CN 201010182462 A CN201010182462 A CN 201010182462A CN 201010182462 A CN201010182462 A CN 201010182462A CN 101829193 A CN101829193 A CN 101829193A
- Authority
- CN
- China
- Prior art keywords
- time
- parts
- preparation
- cervical erosion
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003628 erosive effect Effects 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 239000002131 composite material Substances 0.000 title abstract 6
- 229940079593 drug Drugs 0.000 title description 3
- 239000000284 extract Substances 0.000 claims abstract description 62
- 244000166124 Eucalyptus globulus Species 0.000 claims abstract description 23
- 235000004692 Eucalyptus globulus Nutrition 0.000 claims abstract description 23
- 241000238675 Periplaneta americana Species 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 42
- 239000000706 filtrate Substances 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 238000001914 filtration Methods 0.000 claims description 24
- 239000002674 ointment Substances 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 22
- 229920003266 Leaf® Polymers 0.000 claims description 20
- 239000008194 pharmaceutical composition Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 17
- 239000008213 purified water Substances 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 13
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 235000014593 oils and fats Nutrition 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 239000000890 drug combination Substances 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims description 3
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 14
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 238000009835 boiling Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 241000131808 Scolopendra Species 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 238000001050 pharmacotherapy Methods 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- -1 violent Chemical compound 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- BRTLKRNVNFIOPJ-UHFFFAOYSA-N Betaine homarine Chemical compound C[N+]1=CC=CC=C1C([O-])=O BRTLKRNVNFIOPJ-UHFFFAOYSA-N 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 241000238659 Blatta Species 0.000 description 1
- 241000238660 Blattidae Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000238661 Periplaneta Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 102100029677 Trehalase Human genes 0.000 description 1
- 108010087472 Trehalase Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 201000003988 chronic cervicitis Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000315 cryotherapy Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229940093497 ergothioneine Drugs 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000009969 fructus bruceae Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine composite for treating cervical erosion and a preparation method thereof. The medicine composite mainly comprises a mixture of active ingredients prepared from periplaneta Americana extract, fructus cnidii, radix sophorae flavescentis and eucalyptus globulus leaf, and the active ingredients are in the following proportion by weight: 1,000 parts of periplaneta Americana extract, 10-1,800 parts of fructus cnidii, 15-1,800 parts of radix sophorae flavescentis and 20-3,000 parts of eucalyptus globulus leaf. The preparation method of the medicine composite for treating cervical erosion comprises the following steps of: extracting the periplaneta Americana extract; mixing and extracting the fructus cnidii, the radix sophorae flavescentis and the eucalyptus globulus leaf; mixing and preparing the medicine composite. In the invention, the medicine composite has simple preparation method, gives full play to the function of the periplaneta Americana extract, effectively improves the curative effect on the cervical erosion, is convenient to use, has tiny toxic and side effects, and is a new medicament worthy of generalization.
Description
Technical field
The present invention relates to medical technical field, be specifically related to a kind of pharmaceutical composition for the treatment of cervical erosion and preparation method thereof.
Background technology
It is documented that periplaneta americana is the insecticide of volume maximum in the Blattidae, originates in South America, periplaneta americana is traditional Chinese crude drug, is used as medicine its property plug salty in the mouth with dry and bright adult, poisonous, acid is arranged, functions such as dissipating blood stasis, removing food stagnancy, detoxifcation, diuretic, detumescence are arranged; Curing mainly infantile malnutrition, tonsillitis, health enclosed mass, carbuncle skin ulcer swells and ache and Scolopendra, venom etc.
Along with science and technology constantly develops, after years of research and found that in recent years the periplaneta americana epidermis contains sclerotin and chitin, elements such as bromine, zinc, nickel, violent, potassium, calcium, titanium, chlorine, sulfur, silicon, aluminum, magnesium; Muscle hydrolysis 13 seed amino acids; Its alcohol extract has the obvious suppression effect to cancerous cell, and cardiovascular disease is had tangible curative effect.In addition, health storage vitamin B
1, B
2, nicotinic acid and ascorbic acid etc., lymph contain trehalose, trehalase, glycoprotein, inositol, protocatechuic acid Fructus Vitis viniferae glycoside etc.All contain ergothioneine, 1-methyl-2-pyridinium carboxylate, trigonelline, glycine, betanin, anus alkali, trimethylamine, adenine etc.Clinical main application has: treat infantile malnutrition, control the carbuncle pyogenic infections from tumour or sore, control the Scolopendra wound, control innominate toxic swelling, control the worm venom.But also have periplaneta americana and medical herbs compatibility auxiliary treatment colon cancer.American-cockroach-extract can be controlled hepatitis B, and extract A T-2 preparation can cure mainly primary hepatocarcinoma, cardiovascular disease etc.
Notification number is CN 100525781C, name is called " American-cockroach-extract; contain pharmaceutical composition of this extract and preparation method thereof " and publication number is CN1943600A, it is two with the American-cockroach-extract relevant patent documentations of applicant in application in 2006 that name is called " pharmaceutical composition and the new purposes thereof that contain periplaneta americana and ethanol extraction thereof ", it discloses the preparation method and the part medical usage of American-cockroach-extract, in recent years, along with the further research to American-cockroach-extract, American-cockroach-extract has obtained further development in purposes pharmaceutically.
Cervical erosion is the modal a kind of performance of chronic cervicitis, also is the common a kind of disease of married woman.From whole nation statistics, just have one to get cervical erosion among per three women, and cervical erosion also have confidential relation with cervical cancer.Therefore actively prevent and treat cervical erosion to ensureing that WomanHealth has significant meaning.For treatment cervical erosion, commonly used clinically have five big methods such as pharmacotherapy, isotope therapy, physiotherapy, cryotherapy, cervix uteri excision.Clinical practice shows that said method cuts both ways, and curative effect difference is bigger.And middle-aged women is as the group of people at high risk of cervical erosion, more acceptant pharmacotherapy.Yet existing medicine still is difficult to fully up to expectations for treatment cervical erosion.For this reason, the invention provides a kind of new pharmaceutical composition that is used for the treatment of cervical erosion.
Summary of the invention
The objective of the invention is to: overcome above-mentioned deficiency of the prior art, a kind of pharmaceutical composition and preparation method thereof of treatment cervical erosion of effective raising cure rate is provided.
Purpose of the present invention is achieved through the following technical solutions: a kind of pharmaceutical composition for the treatment of cervical erosion is provided, it is characterized in that: the main component of described pharmaceutical composition and mass parts thereof are such as shown in down: 1000 parts of American-cockroach-extracts; Fructus Cnidii 10-1800 part; Radix Sophorae Flavescentis 15-1800 part; Eucalyptus globulus Labill leaf 20-3000 part.
The proportioning of one of preferred version of the pharmaceutical composition of above-mentioned treatment cervical erosion is: 1000 parts of American-cockroach-extracts; 800 parts of Fructus Cnidiis; 1200 parts of Radix Sophorae Flavescentiss; 300 parts of Eucalyptus globulus Labill leafs.
Two proportioning of the preferred version of the pharmaceutical composition of above-mentioned treatment cervical erosion is: 1000 parts of American-cockroach-extracts; 1200 parts of Fructus Cnidiis; 800 parts of Radix Sophorae Flavescentiss; 1800 parts of Eucalyptus globulus Labill leafs.
The preparation of drug combination method of above-mentioned treatment cervical erosion may further comprise the steps:
1., the preparation of American-cockroach-extract:
A, coarse crushing: exsiccant periplaneta americana is pulverized, make the periplaneta americana coarse powder;
B, immersion: will add the water of 3～5 times of amounts in the coarse powder among the step a, soak and made the coarse powder mixed liquor in 0.5～2 hour, soaking temperature is 70 ℃～78 ℃, and the coarse powder mixed liquor adopts the method that decocts to carry out three times and extracts, and makes extracting solution;
C, three extractions: the coarse powder mixed liquor is carried out the first time extract, extraction time is 7～9 hours; Carry out the second time then behind the water that adds 2～4 times of amounts of surplus liquid in the surplus liquid after extracting for the first time and extract, extraction time is 5～7 hours; Extract for the third time behind the water that adds 2～4 times of amounts of surplus liquid in the surplus liquid after extracting for the second time at last, extraction time is 3～5 hours;
D, filtration for the first time: the extracting solution that three times are extracted among the step c is merged mixing, filter then and make one-level filtrate;
E, concentrated for the first time: relative density was 1.05～1.25 one-level concentrated solution when the one-level filtrate in the steps d was concentrated into 70 ℃～90 ℃;
F, alcoholization are handled: add the ethanol that concentration is 93%w/w～97%w/w in the one-level concentrated solution that makes in step e gradually, and fully stir, making it contain the alcohol amount reaches till 45%～55%, under 70 ℃～90 ℃ temperature conditions, be incubated 20～40 minutes, left standstill then 10～14 hours, and made solution of alcoholized;
G, filtration for the second time: the solution of alcoholized among the step f is discarded the upper strata oils and fats, and lower floor's medicinal liquid filters and makes secondary filtrate;
H, the second time concentrate: after the secondary filtrate in the step g was carried out the ethanol recycling, relative density was 1.20～1.25 secondary concentrated solution when being concentrated into 70 ℃～90 ℃;
I, unguentum preparation: the unguentum that the secondary concentrated solution among the step h is concentrated into moisture≤25%～35% under condition of normal pressure;
J, extract preparation: according to unguentum: the ratio of purified water: glycerol=1000g: 800ml～1200ml: 4ml～6ml adds purified water and glycerol in unguentum, stir, through plate-and-frame filtration, after filtrate is boiled 30 minutes, be chilled to room temperature, promptly get American-cockroach-extract, standby;
2., Fructus Cnidii, Radix Sophorae Flavescentis, Eucalyptus globulus Labill leaf are decocted with water three times, 2～4 hours for the first time, 1～3 hour for the second time, 1～3 hour for the third time, decocting liquid filtered filtrate merging, and sheet frame filters, and is concentrated into an amount of, standby;
3., with step 1. with step in 2. prepared two kinds of extracts mix and stir, through plate-and-frame filtration, after filtrate is boiled 20～40 minutes, again through the autoclave sterilization postcooling to room temperature, promptly get patent medicine.
Amount of water is 4 times of amounts in above-mentioned steps b, and soak time is 1 hour, and soaking temperature is 74 ℃.
At the autoclave sterilization of above-mentioned steps described in 3. is to carry out sterilization under 115 ℃～127 ℃ of temperature, pressure are the condition of 0.05Mpa～0.15Mpa, and sterilization time is 25～35 minutes.
In sum, the preparation of drug combination method that is used for the treatment of cervical erosion provided by the present invention is simple, and has given full play to the effect of American-cockroach-extract, has effectively improved the curative effect to cervical erosion, and easy to use, toxic and side effects is little, is a kind of new medicine that is worthy to be popularized.
The specific embodiment
Below in conjunction with embodiment the specific embodiment of the present invention is described in further detail:
The main component of the pharmaceutical composition of treatment cervical erosion provided by the present invention and mass parts ratio thereof are: 1000 parts of American-cockroach-extracts; Fructus Cnidii 10-1800 part; Radix Sophorae Flavescentis 15-1800 part; Eucalyptus globulus Labill leaf 20-3000 part.
The proportioning of one of preferred version of the pharmaceutical composition of above-mentioned treatment cervical erosion is: 1000 parts of American-cockroach-extracts; 800 parts of Fructus Cnidiis; 1200 parts of Radix Sophorae Flavescentiss; 300 parts of Eucalyptus globulus Labill leafs.
Two proportioning of the preferred version of the pharmaceutical composition of above-mentioned treatment cervical erosion is: 1000 parts of American-cockroach-extracts; 1200 parts of Fructus Cnidiis; 800 parts of Radix Sophorae Flavescentiss; 1800 parts of Eucalyptus globulus Labill leafs.
The preparation of drug combination method of above-mentioned treatment cervical erosion may further comprise the steps:
1., the preparation of American-cockroach-extract:
A, coarse crushing: exsiccant periplaneta americana is pulverized, make the periplaneta americana coarse powder;
B, immersion: will add the water of 3～5 times of amounts in the coarse powder among the step a, soak and made the coarse powder mixed liquor in 0.5～2 hour, soaking temperature is 70 ℃～78 ℃, and the coarse powder mixed liquor adopts the method that decocts to carry out three times and extracts, and makes extracting solution;
C, three extractions: the coarse powder mixed liquor is carried out the first time extract, extraction time is 7～9 hours; Carry out the second time then behind the water that adds 2～4 times of amounts of surplus liquid in the surplus liquid after extracting for the first time and extract, extraction time is 5～7 hours; Extract for the third time behind the water that adds 2～4 times of amounts of surplus liquid in the surplus liquid after extracting for the second time at last, extraction time is 3～5 hours;
D, filtration for the first time: the extracting solution that three times are extracted among the step c is merged mixing, filter then and make one-level filtrate;
E, concentrated for the first time: relative density was 1.05～1.25 one-level concentrated solution when the one-level filtrate in the steps d was concentrated into 70 ℃～90 ℃;
F, alcoholization are handled: add the ethanol that concentration is 93%w/w～97%w/w in the one-level concentrated solution that makes in step e gradually, and fully stir, making it contain the alcohol amount reaches till 45%～55%, under 70 ℃～90 ℃ temperature conditions, be incubated 20～40 minutes, left standstill then 10～14 hours, and made solution of alcoholized;
G, filtration for the second time: the solution of alcoholized among the step f is discarded the upper strata oils and fats, and lower floor's medicinal liquid filters and makes secondary filtrate;
H, the second time concentrate: after the secondary filtrate in the step g was carried out the ethanol recycling, relative density was 1.20～1.25 secondary concentrated solution when being concentrated into 70 ℃～90 ℃;
I, unguentum preparation: the unguentum that the secondary concentrated solution among the step h is concentrated into moisture≤25%～35% under condition of normal pressure;
J, extract preparation: according to unguentum: the ratio of purified water: glycerol=1000g: 800ml～1200ml: 4ml～6ml adds purified water and glycerol in unguentum, stir, through plate-and-frame filtration, after filtrate is boiled 30 minutes, be chilled to room temperature, promptly get American-cockroach-extract, standby;
2., Fructus Cnidii, Radix Sophorae Flavescentis, Eucalyptus globulus Labill leaf are decocted with water three times, 2～4 hours for the first time, 1～3 hour for the second time, 1～3 hour for the third time, decocting liquid filtered filtrate merging, and sheet frame filters, and is concentrated into an amount of, standby;
3., with step 1. with step in 2. prepared two kinds of extracts mix and stir, through plate-and-frame filtration, after filtrate is boiled 20～40 minutes, again through the autoclave sterilization postcooling to room temperature, promptly get patent medicine.
Amount of water is 4 times of amounts in above-mentioned steps b, and soak time is 1 hour, and soaking temperature is 74 ℃.
At the autoclave sterilization of above-mentioned steps described in 3. is to carry out sterilization under 115 ℃～127 ℃ of temperature, pressure are the condition of 0.05Mpa～0.15Mpa, and sterilization time is 25～35 minutes.
Embodiment 1:
The prescription that is adopted is: 1000 parts of American-cockroach-extracts; 800 parts of Fructus Cnidiis; 1200 parts of Radix Sophorae Flavescentiss; 300 parts of Eucalyptus globulus Labill leafs.
Preparation method is: with exsiccant periplaneta americana coarse crushing, every 100Kg coarse powder adds 300Kg water, soaks after 0.5 hour, and temperature is extracted three times about 70 ℃, 7 hours for the first time; For the second time add water 200Kg, extracted 5 hours; Add water 200Kg for the third time, extracted 3 hours.Merge three times extracting solution, filter, when filtrate was concentrated into relative density and is 1.05 (70 ℃), adding concentration was the ethanol of 93%w/w, make that to become to contain alcohol amount be 45%, 70 ℃ of insulated and stirred 20 minutes left standstill 10 hours, discarded the upper strata oils and fats, lower floor's medical filtration, filtrate recycling ethanol, being evaporated to relative density is 1.20 (70 ℃), normal pressure is concentrated into the unguentum of moisture≤25%; According to unguentum: the ratio of purified water: glycerol=1000g: 1000ml: 5ml adds purified water and glycerol in unguentum, stir, and through plate-and-frame filtration, filtrate is chilled to room temperature after boiling 30 minutes, promptly gets American-cockroach-extract, and is standby; Fructus Cnidii, Radix Sophorae Flavescentis, Eucalyptus globulus Labill leaf are decocted with water three times, and 2 hours for the first time, 1 hour for the second time, 1 hour for the third time, decocting liquid filtered filtrate merging, and sheet frame filters, and is concentrated into an amount of, standby; To stir after above-mentioned two kinds of extracts mixing, through plate-and-frame filtration, after filtrate was boiled 20 minutes, again through 115 ℃, pressure was 0.05Mpa, sterilized 25 minutes, was chilled to room temperature, promptly.
Embodiment 2:
The prescription that is adopted is: 1000 parts of American-cockroach-extracts; 1000 parts of American-cockroach-extracts; 1200 parts of Fructus Cnidiis; 800 parts of Radix Sophorae Flavescentiss; 1800 parts of Eucalyptus globulus Labill leafs.
Preparation method is: with exsiccant periplaneta americana coarse crushing, every 100Kg coarse powder adds 500Kg water, soaks after 2 hours, and temperature is extracted three times about 78 ℃, 9 hours for the first time; For the second time add water 400Kg, extracted 7 hours; Add water 400Kg for the third time, extracted 5 hours.Merge three times extracting solution, filter, when filtrate was concentrated into relative density and is 1.25 (90 ℃), adding concentration was the ethanol of 97%w/w, make that to become to contain alcohol amount be 55%, 90 ℃ of insulated and stirred 40 minutes left standstill 14 hours, discarded the upper strata oils and fats, lower floor's medical filtration, filtrate recycling ethanol, being evaporated to relative density is 1.25 (90 ℃), normal pressure is concentrated into the unguentum of moisture≤35%; According to unguentum: the ratio of purified water: glycerol=1000g: 1200ml: 6ml adds purified water and glycerol in unguentum, stir, and through plate-and-frame filtration, filtrate is chilled to room temperature after boiling 30 minutes, promptly gets American-cockroach-extract, and is standby; Fructus Cnidii, Radix Sophorae Flavescentis, Eucalyptus globulus Labill leaf are decocted with water three times, and 4 hours for the first time, 3 hours for the second time, 3 hours for the third time, decocting liquid filtered filtrate merging, and sheet frame filters, and is concentrated into an amount of, standby; To stir after above-mentioned two kinds of extracts mixing, through plate-and-frame filtration, after filtrate was boiled 40 minutes, again through 127 ℃, pressure was 0.15Mpa, sterilized 35 minutes, was chilled to room temperature, promptly.
Embodiment 3:
The prescription that is adopted is: 1000 parts of American-cockroach-extracts; 1000 parts of Fructus Cnidiis; 1000 parts of Radix Sophorae Flavescentiss; 1000 parts of Eucalyptus globulus Labill leafs.
Preparation method is: with exsiccant periplaneta americana coarse crushing, every 100Kg coarse powder adds 400Kg water, soaks after 1 hour, and temperature is extracted three times about 74 ℃, 8 hours for the first time; For the second time add water 300Kg, extracted 6 hours; Add water 300Kg for the third time, extracted 4 hours.Merge three times extracting solution, filter, when filtrate was concentrated into relative density and is 1.15 (80 ℃), adding concentration was the ethanol of 95%w/w, make that to become to contain alcohol amount be 50%, 80 ℃ of insulated and stirred 30 minutes left standstill 12 hours, discarded the upper strata oils and fats, lower floor's medical filtration, filtrate recycling ethanol, being evaporated to relative density is 1.25 (80 ℃), normal pressure is concentrated into the unguentum of moisture≤30%; According to unguentum: the ratio of purified water: glycerol=1000g: 800ml: 4ml adds purified water and glycerol in unguentum, stir, and through plate-and-frame filtration, filtrate is chilled to room temperature after boiling 30 minutes, promptly gets American-cockroach-extract, and is standby; Fructus Cnidii, Radix Sophorae Flavescentis, Eucalyptus globulus Labill leaf are decocted with water three times, and 3 hours for the first time, 2 hours for the second time, 2 hours for the third time, decocting liquid filtered filtrate merging, and sheet frame filters, and is concentrated into an amount of, standby; To stir after above-mentioned two kinds of extracts mixing, through plate-and-frame filtration, after filtrate was boiled 35 minutes, again through 121 ℃, pressure was 0.1Mpa, sterilized 30 minutes, was chilled to room temperature, promptly.
Embodiment 4:
The prescription that is adopted is: 1000 parts of American-cockroach-extracts; 600 parts of Fructus Cnidiis; 400 parts of Radix Sophorae Flavescentiss; 2000 parts of Eucalyptus globulus Labill leafs.
Preparation method is: with exsiccant periplaneta americana coarse crushing, every 100Kg coarse powder adds 380Kg water, soaks after 0.8 hour, and temperature is extracted three times about 74 ℃, 7.5 hours for the first time; For the second time add water 280Kg, extracted 5 hours; Add water 280Kg for the third time, extracted 3 hours.Merge three times extracting solution, filter, when filtrate was concentrated into relative density and is 1.2 (80 ℃), adding concentration was the ethanol of 95%w/w, make that to become to contain alcohol amount be 50%, 80 ℃ of insulated and stirred 30 minutes left standstill 11 hours, discarded the upper strata oils and fats, lower floor's medical filtration, filtrate recycling ethanol, being evaporated to relative density is 1.20 (80 ℃), normal pressure is concentrated into the unguentum of moisture≤30%; According to unguentum: the ratio of purified water: glycerol=1000g: 1100ml: 6ml adds purified water and glycerol in unguentum, stir, and through plate-and-frame filtration, filtrate is chilled to room temperature after boiling 30 minutes, promptly gets American-cockroach-extract, and is standby; Fructus Cnidii, Radix Sophorae Flavescentis, Eucalyptus globulus Labill leaf are decocted with water three times, and 2 hours for the first time, 2 hours for the second time, 2 hours for the third time, decocting liquid filtered filtrate merging, and sheet frame filters, and is concentrated into an amount of, standby; To stir after above-mentioned two kinds of extracts mixing, through plate-and-frame filtration, after filtrate was boiled 30 minutes, again through 121 ℃, pressure was 0.1Mpa, sterilized 30 minutes, was chilled to room temperature, promptly.
The pharmaceutical composition of treatment cervical erosion provided by the present invention can be made various ways such as tablet, suppository, capsule, is beneficial to satisfy different patients' medication custom.
The clinical testing data of cervical erosion cure rate:
One, patient's classified data:
Patients of cervical ruin 100 examples meet diagnostic criteria.Be divided into treatment group and matched group at random, 50 examples are organized in treatment, 16～40 years old age; Matched group 50 examples, 16～40 years old age.The two groups of patient ages and the course of disease are learned processing by statistics, and difference does not have the significance meaning, has comparability.
Two, Therapeutic Method:
The treatment group: get prepared suppository according to the present invention, in vagina administration, one time one, once-a-day.
Matched group: FUYANLING, in vagina administration, once two, once-a-day.
Three, curative effect comparative result:
Table 1 is depicted as two groups of curative effects relatively, and wherein 50 examples are organized in treatment, cure 48 examples, and cure rate is 96.00%, and total effective rate is 100%; Matched group 50 examples are cured 36 examples, and cure rate is 72.00%, and total effective rate is 92.00%.Table 2 is depicted as two groups of 7 days curative effects relatively, treats in 7 days, and treatment group cure rate is 82.00%, and the matched group cure rate is 64.00%.This shows that treatment group curative effect obviously is better than matched group.(n number of delegates in table 1 and the table 2)
Table 1
Table 2
| Group | ??n | 7 days healing patient numbers | 7 days cure rates (%) |
| The treatment group | ??50 | ??42 | ?82.00 |
| Matched group | ??50 | ??32 | ?64.00 |
Four, conclusion (of pressure testing):
Cervical erosion is clinical common gynaecopathia, mostly occurs in married woman crowd, and the characteristics of outbreak are repeatedly arranged.The generation of cervical erosion is relevant with multiple factor, and common have infection, immunity or the like.FUYANLING is a kind of medicine that is usually used in the cervical erosion treatment, and certain curative effect is arranged.Periplaneta americana is a kind of insecticide, be commonly called as Blatta seu periplaneta, body contains the various active composition, its extract main component is polyalcohols and peptide class active substance, confirm to have promotion epithelial cell, granulation tissue growth through pharmacological research, promote wound repair, the effect of enhance immunity, but do not have antibacterial action, the medicine that American-cockroach-extract and Fructus Bruceae, Rhizoma Acori Graminei and Folium Artemisiae Argyi are made not only can infection, simultaneously can promote the cervical erosion tissue repair, improve the cervical erosion ulcer healing rate, shorten the cervical erosion healing time.Comparing data shows that the curative effect that this medicine is used for the treatment of cervical erosion obviously is better than medicine FUYANLING commonly used.
Though in conjunction with specific embodiments the specific embodiment of the present invention has been done to describe in detail, should not be construed as is limitation of the invention.In the protection domain that claims limited, various modifications that those skilled in the art can make without creative work or distortion still belong to the protection domain of this patent.
Claims (6)
1. pharmaceutical composition for the treatment of cervical erosion is characterized in that: the main component of described pharmaceutical composition and mass parts thereof are such as shown in down:
1000 parts of American-cockroach-extracts;
Fructus Cnidii 10-1800 part;
Radix Sophorae Flavescentis 15-1800 part;
Eucalyptus globulus Labill leaf 20-3000 part.
2. the pharmaceutical composition of treatment cervical erosion according to claim 1 is characterized in that: the main component of described pharmaceutical composition and mass parts thereof are such as shown in down:
1000 parts of American-cockroach-extracts;
800 parts of Fructus Cnidiis;
1200 parts of Radix Sophorae Flavescentiss;
300 parts of Eucalyptus globulus Labill leafs.
3. the pharmaceutical composition of treatment cervical erosion according to claim 1 is characterized in that: the main component of described pharmaceutical composition and mass parts thereof are such as shown in down:
1000 parts of American-cockroach-extracts;
1200 parts of Fructus Cnidiis;
800 parts of Radix Sophorae Flavescentiss;
1800 parts of Eucalyptus globulus Labill leafs.
4. the preparation of drug combination method of a claim 1,2 or 3 described treatment cervical erosion, it is characterized in that: described preparation method may further comprise the steps:
1., the preparation of American-cockroach-extract:
A, coarse crushing: exsiccant periplaneta americana is pulverized, make the periplaneta americana coarse powder;
B, immersion: will add the water of 3～5 times of amounts in the coarse powder among the step a, soak and made the coarse powder mixed liquor in 0.5～2 hour, soaking temperature is 70 ℃～78 ℃, and the coarse powder mixed liquor adopts the method that decocts to carry out three times and extracts, and makes extracting solution;
C, three extractions: the coarse powder mixed liquor is carried out the first time extract, extraction time is 7～9 hours; Carry out the second time then behind the water that adds 2～4 times of amounts of surplus liquid in the surplus liquid after extracting for the first time and extract, extraction time is 5～7 hours; Extract for the third time behind the water that adds 2～4 times of amounts of surplus liquid in the surplus liquid after extracting for the second time at last, extraction time is 3～5 hours;
D, filtration for the first time: the extracting solution that three times are extracted among the step c is merged mixing, filter then and make one-level filtrate;
E, concentrated for the first time: relative density was 1.05～1.25 one-level concentrated solution when the one-level filtrate in the steps d was concentrated into 70 ℃～90 ℃;
F, alcoholization are handled: add the ethanol that concentration is 93%w/w～97%w/w in the one-level concentrated solution that makes in step e gradually, and fully stir, making it contain the alcohol amount reaches till 45%～55%, under 70 ℃～90 ℃ temperature conditions, be incubated 20～40 minutes, left standstill then 10～14 hours, and made solution of alcoholized;
G, filtration for the second time: the solution of alcoholized among the step f is discarded the upper strata oils and fats, and lower floor's medicinal liquid filters and makes secondary filtrate;
H, the second time concentrate: after the secondary filtrate in the step g was carried out the ethanol recycling, relative density was 1.20～1.25 secondary concentrated solution when being concentrated into 70 ℃～90 ℃;
I, unguentum preparation: the unguentum that the secondary concentrated solution among the step h is concentrated into moisture≤25%～35% under condition of normal pressure;
J, extract preparation: according to unguentum: the ratio of purified water: glycerol=1000g: 800ml～1200ml: 4ml～6ml adds purified water and glycerol in unguentum, stir, through plate-and-frame filtration, after filtrate is boiled 30 minutes, be chilled to room temperature, promptly get American-cockroach-extract, standby;
2., Fructus Cnidii, Radix Sophorae Flavescentis, Eucalyptus globulus Labill leaf are decocted with water three times, 2～4 hours for the first time, 1～3 hour for the second time, 1～3 hour for the third time, decocting liquid filtered filtrate merging, and sheet frame filters, and is concentrated into an amount of, standby;
3., with step 1. with step in 2. prepared two kinds of extracts mix and stir, through plate-and-frame filtration, after filtrate is boiled 20～40 minutes, again through the autoclave sterilization postcooling to room temperature, promptly get patent medicine.
5. the preparation of drug combination method of treatment cervical erosion according to claim 4 is characterized in that: amount of water is 4 times of amounts among the described step b, and soak time is 1 hour, and soaking temperature is 74 ℃.
6. the preparation of drug combination method of treatment cervical erosion according to claim 4, it is characterized in that: described step 3. in autoclave sterilization be under 115 ℃～127 ℃ of temperature, pressure are the condition of 0.05Mpa～0.15Mpa, to carry out sterilization, sterilization time is 25～35 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101824621A CN101829193B (en) | 2010-05-25 | 2010-05-25 | Medicine composite for treating cervical erosion and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101824621A CN101829193B (en) | 2010-05-25 | 2010-05-25 | Medicine composite for treating cervical erosion and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101829193A true CN101829193A (en) | 2010-09-15 |
| CN101829193B CN101829193B (en) | 2012-05-30 |
Family
ID=42713514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101824621A Active CN101829193B (en) | 2010-05-25 | 2010-05-25 | Medicine composite for treating cervical erosion and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101829193B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20120118A1 (en) * | 2012-01-31 | 2013-08-01 | Giuseppe Zummo | COMPOSITION FOR THE TREATMENT OF SKIN DISEASES. |
| CN106937979A (en) * | 2017-03-16 | 2017-07-11 | 姜海地 | A kind of composition and external wash liquid for treating genital system diseases |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1135895A (en) * | 1995-05-18 | 1996-11-20 | 杨辉 | Medicine for treating female genital tract diseases and its use |
| CN1351876A (en) * | 2000-11-14 | 2002-06-05 | 深圳市中药总厂 | Chinese medicine external use lotion for treating skin diseases and its preparing method |
| CN1939345A (en) * | 2006-09-30 | 2007-04-04 | 耿福能 | American falx extract, medicinal composition containing it and its making method |
-
2010
- 2010-05-25 CN CN2010101824621A patent/CN101829193B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1135895A (en) * | 1995-05-18 | 1996-11-20 | 杨辉 | Medicine for treating female genital tract diseases and its use |
| CN1351876A (en) * | 2000-11-14 | 2002-06-05 | 深圳市中药总厂 | Chinese medicine external use lotion for treating skin diseases and its preparing method |
| CN1939345A (en) * | 2006-09-30 | 2007-04-04 | 耿福能 | American falx extract, medicinal composition containing it and its making method |
Non-Patent Citations (1)
| Title |
|---|
| 《邯郸医学高等专科学校学报》 20051231 张慧等 复方双唑泰栓治疗多种类型阴道炎效果观察 第18卷, 第2期 2 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20120118A1 (en) * | 2012-01-31 | 2013-08-01 | Giuseppe Zummo | COMPOSITION FOR THE TREATMENT OF SKIN DISEASES. |
| CN106937979A (en) * | 2017-03-16 | 2017-07-11 | 姜海地 | A kind of composition and external wash liquid for treating genital system diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101829193B (en) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101837018A (en) | American cockroach medicinal composition for curing ulcers or ulcerative inflammation and preparation method thereof | |
| CN1305513C (en) | Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process | |
| CN101829178B (en) | Medicine composition for treating diaper rash and preparation method thereof | |
| CN105362295A (en) | Periplaneta americana pharmaceutical composition for treating acute and chronic faucitis and dental ulcers and preparation method thereof | |
| CN101837019B (en) | American cockroach medicinal composition for curing oral ulcers and preparation method thereof | |
| CN101837095B (en) | American cockroach medicinal composition for curing gastritis and peptic ulcers and preparation method thereof | |
| CN101837045A (en) | American cockroach medicinal composition for curing oral ulcers and preparation method thereof | |
| CN101829193B (en) | Medicine composite for treating cervical erosion and preparation method thereof | |
| CN101822696B (en) | Medicine composite for treating burn and scald and preparation method thereof | |
| CN101837022A (en) | American cockroach medicinal composition for curing gastritis and peptic ulcers and preparation method thereof | |
| CN105770669A (en) | Medicinal preparation for treating colour spots and application thereof | |
| CN101829167B (en) | Medicine composite for treating cervical erosion and preparation method thereof | |
| CN102274317A (en) | Chinese medicinal composition for treating cancers and preparation method thereof | |
| CN101829162B (en) | Pharmaceutical composition for treating allergic rhinitis and preparation method thereof | |
| CN101829253B (en) | Medicine composite for treating cervical erosion and preparation method thereof | |
| CN101829219B (en) | Periplaneta Americana pharmaceutical composition for treating ulcerative colitis and preparation method thereof | |
| CN101837020B (en) | American cockroach medicinal composition for curing oral ulcers and preparation method thereof | |
| CN101829168B (en) | Pharmaceutical composition for treating condyloma acuminatum and herpes, as well as preparation method thereof | |
| CN101837023A (en) | American cockroach medicinal composition for curing gastritis and peptic ulcers and preparation method thereof | |
| CN101829220B (en) | Periplaneta Americana pharmaceutical composition for treating ulcerative colitis and preparation method thereof | |
| CN101829221B (en) | American cockroach medicament composition for treating piles and anal fissure and preparation method thereof | |
| CN101829177B (en) | Medicine composition for postoperative wound restoration and preparation method thereof | |
| CN104491268A (en) | Traditional Chinese medicine capsule for treating lymphoma and preparation method thereof | |
| CN108635560A (en) | A kind of Chinese medicine and preparation method thereof for treating lymthoma | |
| CN107362296B (en) | Medicine for treating benign tumor of skin and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200824 Address after: NO.115, section 3, Airport Road, Xichang City, Liangshan Yi Autonomous Prefecture, Sichuan Province Patentee after: SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL Co.,Ltd. Address before: 15, building 88, building B, four Wei building, No. 610031 Camp Road, Sichuan, Chengdu Patentee before: Geng Funeng |